دورية أكاديمية

Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response.

التفاصيل البيبلوغرافية
العنوان: Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response.
المؤلفون: Chan HHL; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong. henryhl.chan@polyu.edu.hk.; Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong. henryhl.chan@polyu.edu.hk.; Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Kowloon, Hong Kong. henryhl.chan@polyu.edu.hk.; Centre for Eye and Vision Research Limited, 17W Hong Kong Science Park, Shatin, Hong Kong. henryhl.chan@polyu.edu.hk.; University Research Facilities in Behavioral and Systems Neuroscience (UBSN), The Hong Kong Polytechnic University, Kowloon, Hong Kong. henryhl.chan@polyu.edu.hk., Choi KY; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong.; Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong., Ng ALK; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Choy BNK; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Chan JCH; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Chan SSH; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong.; Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong., Li SZC; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong.; Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong., Yu WY; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong.
المصدر: Scientific reports [Sci Rep] 2022 Jul 08; Vol. 12 (1), pp. 11588. Date of Electronic Publication: 2022 Jul 08.
نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Atropine* , Myopia*/drug therapy, Axial Length, Eye ; Child ; Disease Progression ; Humans ; Ophthalmic Solutions ; Refraction, Ocular ; Vision Tests
مستخلص: This study aimed to evaluate the efficacy of 18-month 0.01% atropine in 61 myopic children (aged 7-10) and the relationship with central retinal response (by multifocal electroretinogram [mfERG]) in a double-masked randomized placebo-controlled clinical trial. Global-flash mfERG was measured at baseline, while cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at baseline and at 6-month intervals. Annualized change in SER and AL were compared between atropine and control groups, and the relationships with baseline mfERG were evaluated. Changes in SER (-0.70 ± 0.39D vs. -0.66 ± 0.41D, p = 0.63) and AL (0.32 ± 0.16 mm vs. 0.30 ± 0.22 mm, p = 0.52) were similar in atropine and control groups. Interestingly, in the placebo group, mfERG amplitude was negatively correlated with axial elongation (R p  = -0.44, p = 0.03) as in our previous study. However, in the atropine group, an opposite trend was observed that axial elongation was positively correlated with mfERG amplitude (R a  = 0.37, p = 0.04). Annualized myopia progression demonstrated similar opposite effect between atropine and placebo groups but did not reach statistical significance. An ERG screening protocol may be warranted to identify suitable candidates to reduce the likelihood of an unfavorable treatment response by 0.01% atropine.
(© 2022. The Author(s).)
References: Graefes Arch Clin Exp Ophthalmol. 2005 Feb;243(2):132-41. (PMID: 15742211)
JAMA. 2020 Aug 11;324(6):571-580. (PMID: 32780139)
Doc Ophthalmol. 2021 Jun;142(3):315-328. (PMID: 33231734)
Invest Ophthalmol Vis Sci. 2012 Aug 09;53(9):5320-5. (PMID: 22761262)
Doc Ophthalmol. 2008 May;116(3):165-76. (PMID: 17721791)
Ophthalmology. 2021 Aug;128(8):1180-1187. (PMID: 33422558)
Ophthalmology. 2006 Dec;113(12):2285-91. (PMID: 16996612)
Br J Ophthalmol. 2020 Nov;104(11):1535-1541. (PMID: 32086237)
Ophthalmology. 2012 Feb;119(2):347-54. (PMID: 21963266)
Exp Eye Res. 2020 Nov;200:108205. (PMID: 32866531)
Ophthalmology. 2019 Jan;126(1):113-124. (PMID: 30514630)
Ophthalmic Physiol Opt. 2015 Sep;35(5):465-75. (PMID: 26303444)
JAMA Ophthalmol. 2021 Mar 1;139(3):293-300. (PMID: 33443542)
Br J Ophthalmol. 2020 Mar;104(3):363-368. (PMID: 31142465)
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4399–4406. (PMID: 28813575)
JAMA Ophthalmol. 2017 Jun 1;135(6):624-630. (PMID: 28494063)
Prog Retin Eye Res. 2018 Jan;62:134-149. (PMID: 28951126)
Exp Eye Res. 2018 Jul;172:104-111. (PMID: 29608907)
Vision Res. 2008 Jul;48(16):1726-1734. (PMID: 18573515)
Ophthalmology. 2022 Mar;129(3):308-321. (PMID: 34627809)
Biochem Med (Zagreb). 2021 Feb 15;31(1):010502. (PMID: 33380887)
Br J Ophthalmol. 2014 Jan;98(1):40-5. (PMID: 24169657)
Br J Ophthalmol. 2021 Aug 2;:. (PMID: 34340973)
Br J Ophthalmol. 2021 Mar 17;:. (PMID: 33731364)
Am J Ophthalmol. 2014 Feb;157(2):451-457.e1. (PMID: 24315293)
JAMA Netw Open. 2022 Jan 4;5(1):e2143781. (PMID: 35029662)
Am J Ophthalmol. 2015 May;159(5):945-9. (PMID: 25640408)
Ophthalmology. 2016 May;123(5):1036-42. (PMID: 26875007)
Br J Ophthalmol. 2005 Feb;89(2):151-3. (PMID: 15665343)
Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7077-85. (PMID: 22969068)
Invest Ophthalmol Vis Sci. 2002 May;43(5):1673-85. (PMID: 11980890)
المشرفين على المادة: 0 (Ophthalmic Solutions)
7C0697DR9I (Atropine)
تواريخ الأحداث: Date Created: 20220708 Date Completed: 20220712 Latest Revision: 20220915
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9270320
DOI: 10.1038/s41598-022-15686-6
PMID: 35804049
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-022-15686-6